{"id":"W3209159424","doi":"10.1136/ijgc-2021-igcs.2","title":"O002/#43 Randomized phase 3 study of lenvatinib plus pembrolizumab for advanced endometrial cancer (aec): subgroup analysis of patients with DNA mismatch repair deficient (DMMR) tumors","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Università degli Studi di Torino; Università di Bologna; Università degli Studi di Parma","keywords":"Pembrolizumab; Lenvatinib; Medicine; Internal medicine; Oncology; Tolerability; Regimen; Adverse effect; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001645385,0.001853436,0.003703668,0.000398305,0.0004740969,0.001297624,0.0007821225,0.001424213,0.007849168],"category_scores_gemma":[0.001428698,0.0007988075,0.004096047,0.0004707311,0.0007475088,0.0009117007,0.0005096353,0.002874375,0.000978592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008615099,"about_ca_system_score_gemma":0.001593797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001827753,"about_ca_topic_score_gemma":0.006033499,"domain_scores_codex":[0.9994631,0.000268876,0.00003192514,0.00009653447,0.00004004027,0.00009946345],"domain_scores_gemma":[0.9994857,0.0001319837,0.00009707081,0.00006968257,0.00003846842,0.0001770196],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9795538,0.002033076,0.001241487,0.0004228571,0.004021476,0.0000327785,0.00002909151,0.0002913603,0.002280431,0.00008359866,0.001196138,0.008813886],"study_design_scores_gemma":[0.9660206,0.02419441,0.004751077,0.00003270778,0.003025788,0.00002881853,0.00003331737,0.0004543382,0.0002244183,0.0002526942,0.0009591443,0.00002262094],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9780888,0.007304687,0.001061539,0.001506472,0.0009245016,0.003825609,0.003439077,0.0001647594,0.003684436],"genre_scores_gemma":[0.9798738,0.00239378,0.001966153,0.002562227,0.0005835203,0.004140996,0.003563219,0.00005818441,0.004858118],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007849168,"threshold_uncertainty_score":0.02625805,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02673610835872959,"score_gpt":0.3522935343213451,"score_spread":0.3255574259626156,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}